Free Trial

France’s top court strikes down pesticide clause in farming law

French President Emmanuel Macron speaks to the army leaders at the Hotel le Brienne, Sunday, July 13, 2025, ahead of the Bastille Day parade in Paris. (Ludovic Marin, Pool Photo via AP)

Key Points

  • France’s top court has blocked a key pesticide provision in the "Duplomb law," which aimed to allow the return of the banned pesticide acetamiprid.
  • The court ruled that the measure failed to protect the environment and violated France’s constitutional commitment to environmental protection.
  • The proposed law had garnered significant opposition, illustrated by a student-led petition that received over 2 million signatures, highlighting concerns over public health and biodiversity.
  • This decision is considered a setback for President Emmanuel Macron’s government, with critics praising it as a victory for democracy and environmental advocacy.
  • Are You Missing Key Market Insights? Try 5 Weeks of All Access for Only $5 Today. Claim Your Limited-Time Discount.

PARIS (AP) — France’s highest court on Thursday blocked a key part of a contentious farming law that would have brought back a banned pesticide.

The court said that the measure failed to protect the environment and future generations. The rest of the law — known as the “Duplomb law,” after the senator who proposed it — was allowed to stand.

The bill, passed in early July, aimed to loosen rules for farmers and fast-track projects like water storage. It was backed by the government and major farming unions, but met fierce opposition from scientists, health experts and green groups.

At the heart of the outrage was acetamiprid, a pesticide banned in France since 2018 for its role in harming bees and other pollinators. Farmers, especially sugar beet growers, had pushed for its return.

But the court ruled that the proposal wasn't strict enough, and ignored France’s constitutional commitment to environmental protection.

The backlash was swift and widespread. A student-led petition against the law drew more than 2 million signatures — one of the biggest in French history. Opponents said that the bill was rushed through parliament with barely any debate, and warned that it put public health and biodiversity at risk.

The ruling is a blow to President Emmanuel Macron’s government, which had defended the bill until the end.

Critics called the decision a win for democracy and the planet. Some lawmakers have already vowed to push for a full repeal in the coming months.

Acetamiprid is currently approved by the European Union until 2033, and authorized in other member countries.

Where Should You Invest $1,000 Right Now?

Before you make your next trade, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.

Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.

They believe these five stocks are the five best companies for investors to buy now...

See The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without
Palantir & AMD Earnings: Massive Options Setups Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines